These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9844289)

  • 1. [Compliance and asthma--a delphi survey on therapy compliance by by asthma patients in ambulatory care].
    Graf von der Schulenburg JM; Greiner W
    Gesundheitswesen; 1998 Oct; 60(10):558-62. PubMed ID: 9844289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cost of asthma therapy in relation to severity. An empirical study].
    Graf von der Schulenburg JM; Greiner W; Molitor S; Kielhorn A
    Med Klin (Munich); 1996 Oct; 91(10):670-6. PubMed ID: 9019647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a low-cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample.
    Chatkin JM; Blanco DC; Scaglia N; Wagner MB; Fritscher CC
    J Asthma; 2006 May; 43(4):263-6. PubMed ID: 16809238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Asthma therapy in children. Value of long acting beta-mimetic drugs and anti-leukotrienes].
    Nicolai T
    MMW Fortschr Med; 2000 Jun; 142(23):28-31. PubMed ID: 10900948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The quality of asthma treatment in Denmark. How far are we--and how far are our patients?].
    Ulrik CS; Lange P; Plaschke PP; Backer V; Søes-Petersen U; Harving H
    Ugeskr Laeger; 2008 Jan; 170(4):230-4. PubMed ID: 18282453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of asthma controller therapies: influence of disease severity and other variables.
    Navarro RP; Parasuraman B
    Manag Care Interface; 2005 Jun; 18(6):31-40. PubMed ID: 16018297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-inflammatory asthma therapy. Effectiveness depends on compliance].
    MMW Fortschr Med; 2001 Jan; 143(4):46-7. PubMed ID: 11219287
    [No Abstract]   [Full Text] [Related]  

  • 8. Asthma control and compliance in a cohort of adult asthmatics: first survey in Israel.
    Starobin D; Bargutin M; Rosenberg I; Yarmolovsky A; Levi T; Fink G
    Isr Med Assoc J; 2007 May; 9(5):358-60. PubMed ID: 17591372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of prevalence, cost, and outcomes of a combination of salmeterol and fluticasone therapy to common asthma treatments.
    Wang SW; Liu X; Wiener DJ; Sennett C; Bowers BW; Legorreta AP
    Am J Manag Care; 2001 Sep; 7(9):913-22. PubMed ID: 11570024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quality assurance of drug therapy for patients with asthma. Health economic analysis].
    Søndergaard B; Thorleifsson S; Herborg H; Frøkjaer B; Hepler CD; Ersbøll BK
    Ugeskr Laeger; 2000 Jan; 162(4):480-6. PubMed ID: 10697444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.
    Sullivan SD; Turk F
    Allergy; 2008 Jun; 63(6):670-84. PubMed ID: 18445184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of a regional intervention to promote asthma guidelines implementation].
    Geraedts M; Selbmann HK; Meisner C
    Gesundheitswesen; 2002 May; 64(5):235-41. PubMed ID: 12007064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch.
    Tamura G; Ohta K
    Respir Med; 2007 Sep; 101(9):1895-902. PubMed ID: 17587559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma-related health care resource use among patients starting fluticasone or montelukast therapy.
    Allen-Ramey FC; Anstatt DT; Sajjan SG; Markson LE
    Pharmacotherapy; 2005 Dec; 25(12):1752-60. PubMed ID: 16305295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy participation in ambulatory asthma patients: empirical comparison of compliance rates using different operationalization methods for drug compliance].
    Mühlig S; Bergmann KC; Twesten O; Petermann F
    Pneumologie; 2001 Apr; 55(4):177-89. PubMed ID: 11393046
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of anti-asthmatic drugs in Italy: analysis of prescriptions in general practice in the light of guidelines for asthma treatment.
    Poluzzi E; Resi D; Zuccheri P; Motola D; De Ponti F; Vaccheri A; Montanaro N
    Eur J Clin Pharmacol; 2002 Apr; 58(1):55-9. PubMed ID: 11956674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacotherapeutical management of bronchial asthma].
    Leont'ev SL; Mikhaĭlov VG; Nevzorova VP; Sadovnikova RV; Shabashov AF; Lugovkina TK; Leshchenko IV; Bel'tiukov EK; Lebedeva MK
    Klin Med (Mosk); 1998; 76(10):39-41. PubMed ID: 9865016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study.
    Weiss K; Buxton M; Andersson FL; Lamm CJ; Liljas B; Sullivan SD
    Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():21-7. PubMed ID: 16573705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Asthma therapy and compliance].
    Kurz H
    Wien Med Wochenschr; 1998; 148(14):338-41. PubMed ID: 9816646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.